Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Research article

Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patients

Authors: Young Eun Kwon, Seung Hyeok Han, Jeong Hae Kie, Seong Yeong An, Yung Ly Kim, Kyoung Sook Park, Ki Heon Nam, Ah Young Leem, Hyung Jung Oh, Jung Tak Park, Tae Ik Chang, Ea Wha Kang, Shin-Wook Kang, Kyu Hun Choi, Beom Jin Lim, Hyeon Joo Jeong, Tae-Hyun Yoo

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Many studies have shown that clinical characteristics and outcomes differ depending on pathologic variants of focal segmental glomerulosclerosis (FSGS). However, these are not well defined in Asian populations.

Methods

This retrospective study evaluated clinical features and outcomes of pathologic FSGS variants in 111 adult patients between January 2004 and December 2012. Primary outcome was the composite of doubling of baseline serum creatinine concentrations (D-SCr) or onset of end-stage renal disease (ESRD). Secondary outcome included complete (CR) or partial remission (PR).

Results

There were 70 (63.1%), 20 (18.0%), 17 (15.3%), 3 (2.7%), and 1 (0.9%) patients with not-otherwise specified (NOS), tip, perihilar, cellular, and collapsing variants, respectively. At presentation, nephrotic-range proteinuria occurred more commonly in tip lesion than in other variants. The overall 5-year renal survival rate was 76.8%. During a median follow-up of 34.5 months, only 1 (5.0%) patient with a tip lesion reached the composite end point compared to 2 (11.8%) and 12 (17.1%) patients in perihilar and NOS variants, but this difference was not statistically significant in an adjusted Cox model. However, tip lesion was associated with a significantly increased probability of achieving CR (P = 0.044).

Conclusion

Similar to other populations, Korean adult patients with FSGS have distinct clinical features with the exception of a rare frequency of cellular and collapsing variants. Although pathologic variants were not associated with overall outcome, the tip variant exhibited favorable outcome in terms of achieving remission. Further studies are required to delineate long-term outcome and response to treatment of the pathologic variants.
Appendix
Available only for authorised users
Literature
1.
go back to reference Korbet SM: Treatment of primary FSGS in adults. J Am Soc Nephrol. 2012, 23 (11): 1769-1776. 10.1681/ASN.2012040389.CrossRefPubMed Korbet SM: Treatment of primary FSGS in adults. J Am Soc Nephrol. 2012, 23 (11): 1769-1776. 10.1681/ASN.2012040389.CrossRefPubMed
2.
go back to reference Kitiyakara C, Kopp JB, Eggers P: Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol. 2003, 23 (2): 172-182. 10.1053/snep.2003.50025.CrossRefPubMed Kitiyakara C, Kopp JB, Eggers P: Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol. 2003, 23 (2): 172-182. 10.1053/snep.2003.50025.CrossRefPubMed
3.
go back to reference Chang JH, Kim DK, Kim HW, Park SY, Yoo T-H, Kim BS, Kang S-W, Choi KH, Han D-S, Jeong HJ, Lee HY: Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Nephrol Dial Transplant. 2009, 24 (8): 2406-2410. 10.1093/ndt/gfp091.CrossRefPubMed Chang JH, Kim DK, Kim HW, Park SY, Yoo T-H, Kim BS, Kang S-W, Choi KH, Han D-S, Jeong HJ, Lee HY: Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Nephrol Dial Transplant. 2009, 24 (8): 2406-2410. 10.1093/ndt/gfp091.CrossRefPubMed
4.
go back to reference D’Agati VD: The spectrum of focal segmental glomerulosclerosis: new insights. Curr Opin Nephrol Hypertens. 2008, 17 (3): 271-281. 10.1097/MNH.0b013e3282f94a96.CrossRefPubMed D’Agati VD: The spectrum of focal segmental glomerulosclerosis: new insights. Curr Opin Nephrol Hypertens. 2008, 17 (3): 271-281. 10.1097/MNH.0b013e3282f94a96.CrossRefPubMed
5.
go back to reference D’Agati VD, Fogo AB, Bruijn JA, Jennette JC: Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004, 43 (2): 368-382. 10.1053/j.ajkd.2003.10.024.CrossRefPubMed D’Agati VD, Fogo AB, Bruijn JA, Jennette JC: Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004, 43 (2): 368-382. 10.1053/j.ajkd.2003.10.024.CrossRefPubMed
6.
go back to reference Barisoni L, Schnaper HW, Kopp JB: A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol. 2007, 2 (3): 529-542. 10.2215/CJN.04121206.CrossRefPubMed Barisoni L, Schnaper HW, Kopp JB: A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol. 2007, 2 (3): 529-542. 10.2215/CJN.04121206.CrossRefPubMed
7.
go back to reference D’Agati VD, Kaskel FJ, Falk RJ: Focal segmental glomerulosclerosis. N Engl J Med. 2011, 365 (25): 2398-2411. 10.1056/NEJMra1106556.CrossRefPubMed D’Agati VD, Kaskel FJ, Falk RJ: Focal segmental glomerulosclerosis. N Engl J Med. 2011, 365 (25): 2398-2411. 10.1056/NEJMra1106556.CrossRefPubMed
8.
go back to reference D’Agati V: Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol. 2003, 23 (2): 117-134. 10.1053/snep.2003.50012.CrossRefPubMed D’Agati V: Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol. 2003, 23 (2): 117-134. 10.1053/snep.2003.50012.CrossRefPubMed
9.
go back to reference Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ, Jennette JL: Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int. 2006, 69 (5): 920-926. 10.1038/sj.ki.5000160.CrossRefPubMed Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ, Jennette JL: Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int. 2006, 69 (5): 920-926. 10.1038/sj.ki.5000160.CrossRefPubMed
10.
go back to reference D’Agati VD, Alster JM, Jennette JC, Thomas DB, Pullman J, Savino DA, Cohen AH, Gipson DS, Gassman JJ, Radeva MK, Moxey-Mims MM, Friedman AL, Kaskel FJ, Trachtman H, Alpers CE, Fogo AB, Greene TH, Nast CC: Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol. 2013, 8 (3): 399-406. 10.2215/CJN.06100612.CrossRefPubMed D’Agati VD, Alster JM, Jennette JC, Thomas DB, Pullman J, Savino DA, Cohen AH, Gipson DS, Gassman JJ, Radeva MK, Moxey-Mims MM, Friedman AL, Kaskel FJ, Trachtman H, Alpers CE, Fogo AB, Greene TH, Nast CC: Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol. 2013, 8 (3): 399-406. 10.2215/CJN.06100612.CrossRefPubMed
11.
go back to reference Nada R, Kharbanda JK, Bhatti A, Minz RW, Sakhuja V, Joshi K: Primary focal segmental glomerulosclerosis in adults: is the Indian cohort different?. Nephrol Dial Transplant. 2009, 24 (12): 3701-3707. 10.1093/ndt/gfp328.CrossRefPubMed Nada R, Kharbanda JK, Bhatti A, Minz RW, Sakhuja V, Joshi K: Primary focal segmental glomerulosclerosis in adults: is the Indian cohort different?. Nephrol Dial Transplant. 2009, 24 (12): 3701-3707. 10.1093/ndt/gfp328.CrossRefPubMed
12.
go back to reference Deegens JK, Steenbergen EJ, Borm GF, Wetzels JF: Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population—epidemiology and outcome. Nephrol Dial Transplant. 2008, 23 (1): 186-192.CrossRefPubMed Deegens JK, Steenbergen EJ, Borm GF, Wetzels JF: Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population—epidemiology and outcome. Nephrol Dial Transplant. 2008, 23 (1): 186-192.CrossRefPubMed
13.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150 (9): 604-612. 10.7326/0003-4819-150-9-200905050-00006.CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150 (9): 604-612. 10.7326/0003-4819-150-9-200905050-00006.CrossRefPubMedPubMedCentral
14.
go back to reference Chun MJ, Korbet SM, Schwartz MM, Lewis EJ: Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol. 2004, 15 (8): 2169-2177. 10.1097/01.ASN.0000135051.62500.97.CrossRefPubMed Chun MJ, Korbet SM, Schwartz MM, Lewis EJ: Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol. 2004, 15 (8): 2169-2177. 10.1097/01.ASN.0000135051.62500.97.CrossRefPubMed
15.
go back to reference Stokes MB, Markowitz GS, Lin J, Valeri AM, D’Agati VD: Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int. 2004, 65 (5): 1690-1702. 10.1111/j.1523-1755.2004.00563.x.CrossRefPubMed Stokes MB, Markowitz GS, Lin J, Valeri AM, D’Agati VD: Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int. 2004, 65 (5): 1690-1702. 10.1111/j.1523-1755.2004.00563.x.CrossRefPubMed
16.
go back to reference Howie AJ, Pankhurst T, Sarioglu S, Turhan N, Adu D: Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion. Kidney Int. 2005, 67 (3): 987-1001. 10.1111/j.1523-1755.2005.00162.x.CrossRefPubMed Howie AJ, Pankhurst T, Sarioglu S, Turhan N, Adu D: Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion. Kidney Int. 2005, 67 (3): 987-1001. 10.1111/j.1523-1755.2005.00162.x.CrossRefPubMed
17.
go back to reference Stokes MB, Valeri AM, Markowitz GS, D’Agati VD: Cellular focal segmental glomerulosclerosis: clinical and pathologic features. Kidney Int. 2006, 70 (10): 1783-1792. 10.1038/sj.ki.5001903.CrossRefPubMed Stokes MB, Valeri AM, Markowitz GS, D’Agati VD: Cellular focal segmental glomerulosclerosis: clinical and pathologic features. Kidney Int. 2006, 70 (10): 1783-1792. 10.1038/sj.ki.5001903.CrossRefPubMed
18.
go back to reference Shi SF, Wang SX, Zhang YK, Zhao MH, Zou WZ: Clinicopathologic study of different variants of focal segmental glomerulosclerosis. Zhonghua Bing Li Xue Za Zhi. 2007, 36 (1): 11-14.PubMed Shi SF, Wang SX, Zhang YK, Zhao MH, Zou WZ: Clinicopathologic study of different variants of focal segmental glomerulosclerosis. Zhonghua Bing Li Xue Za Zhi. 2007, 36 (1): 11-14.PubMed
19.
go back to reference Tang X, Xu F, Chen DM, Zeng CH, Liu ZH: The clinical course and long-term outcome of primary focal segmental glomerulosclerosis in Chinese adults. Clin Nephrol. 2013, 80 (2): 130-139.CrossRefPubMed Tang X, Xu F, Chen DM, Zeng CH, Liu ZH: The clinical course and long-term outcome of primary focal segmental glomerulosclerosis in Chinese adults. Clin Nephrol. 2013, 80 (2): 130-139.CrossRefPubMed
20.
go back to reference Arias LF, Franco-Alzate C, Rojas SL: Tip variant of focal segmental glomerulosclerosis: outcome and comparison to ‘not otherwise specified’variant. Nephrol Dial Transplant. 2011, 26 (7): 2215-2221. 10.1093/ndt/gfq668.CrossRefPubMed Arias LF, Franco-Alzate C, Rojas SL: Tip variant of focal segmental glomerulosclerosis: outcome and comparison to ‘not otherwise specified’variant. Nephrol Dial Transplant. 2011, 26 (7): 2215-2221. 10.1093/ndt/gfq668.CrossRefPubMed
Metadata
Title
Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patients
Authors
Young Eun Kwon
Seung Hyeok Han
Jeong Hae Kie
Seong Yeong An
Yung Ly Kim
Kyoung Sook Park
Ki Heon Nam
Ah Young Leem
Hyung Jung Oh
Jung Tak Park
Tae Ik Chang
Ea Wha Kang
Shin-Wook Kang
Kyu Hun Choi
Beom Jin Lim
Hyeon Joo Jeong
Tae-Hyun Yoo
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-52

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.